Zoom shares dip amid rising selling pressure

Traders Union
All News
Financial News
Zoom slides 2.77% today to $89.55

Highlights

Zoom unveiled the ZoomMate agentic AI platform on June 1, 2026, targeting improved enterprise communications and productivity.
Annual meeting ratified all key board and compensation proposals amid ongoing share price pressure; CFO Michelle Chang sold 327 shares pre-arranged.
Zoom trades below major moving averages amid bearish technical momentum, but deeply oversold readings suggest a high probability of a near-term rebound within the $87.29–$91.06 range.

Shareholder actions and product launch draw little relief amid ongoing selling

On June 1, 2026, Zoom launched the ZoomMate agentic AI platform, introducing advanced tools focused on streamlining workplace conversations and supporting enterprise clients. On June 15, 2026, Chief Financial Officer Michelle Chang executed a pre-arranged sale of 327 shares under a Rule 10b5-1 trading plan, and now directly holds 30,467 shares. The company also conducted its annual shareholders meeting on June 11, 2026, where board directors, auditor appointments, and executive compensation packages were ratified, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, observes that Zoom remains under heavy short- and medium-term bearish influence, unable to recover above critical moving averages. He points to persistent downside pressure despite the company's AI-driven news and orderly insider trades. Kharitonov remains skeptical about a near-term turnaround since the price is only marginally above its 200-day moving average and still faces resistance at $91.06 and $102.61. The expert notes that even recent bullish technical signals are battling entrenched seller momentum. "Until Zoom reclaims the $91 level on genuine volume, I see this as a stock exposed to further downside risk rather than a clear rebound candidate."

Viktoras Karapetjanc, expert at Traders Union, views Zoom's launch of its agentic AI platform as a strong catalyst for renewed institutional interest and market confidence. He highlights that the recent annual meeting and smooth CFO share transaction signal management stability and clear direction. Karapetjanc sees these developments as reinforcing the longer-term bullish structure, especially with the stock holding above its 200-day average. Technical oversold signals create attractive setups for patient investors as fresh momentum develops. "Despite recent volatility, this market offers multiple setups to benefit from future growth in the evolving digital enterprise space."

Parshwa Turakhiya, analyst, believes Zoom is at a technical crossroads with short-term indicators flashing a rebound opportunity. He notes that sentiment remains cautious but improving, thanks to strong technical support near $87.16 and encouraging signals from momentum oscillators. Turakhiya sees potential for a tactical upswing if bulls reclaim $91.06, while a drop below $87.29 would raise caution. "I’m watching for sentiment shifts to spark a quick breakout or trigger sharper downside — this setup is ideal for nimble traders."

Prices test long-term support as resistance caps further upside

Zoom is currently trading at $89.55, well below the 20-day ($100.11) and 50-day ($96.87) moving averages, indicating clear short- and medium-term bearish pressure, while the price remains above the 200-day average ($87.16), which suggests long-term support is intact. The nearest dynamic resistance is provided by the Ichimoku Kijun level at $102.61, with long-term support situated near the 200-day moving average.

Earlier, analysts noted that Zoom faced persistent short- and medium-term selling pressure despite recent product launches and leadership developments. The current analysis adds a cautiously optimistic shift, highlighting increased prospects for a short-term rebound while emphasizing that sustained gains will depend on buyers defending support near the longer-term average.

Source of Data: ZM Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.